IMRX vs AAPL: Which Stock is Better?
Side-by-side comparison of Immuneering Corp and Apple Inc in 2026
IMRX
Immuneering Corp
$5.70
AAPL
Apple Inc
$259.25
Key Metrics Comparison
| Metric | IMRX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $356.88M | N/A | IMRX |
| P/E Ratio | N/A | 33.01 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | -1.0% | 0.2% | AAPL |
| Gross Margin | 34907.7% | 47.3% | IMRX |
Analyze IMRX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMRX or AAPL a better investment?
Comparing IMRX and AAPL: Immuneering Corp has a market cap of $356.88M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMRX and AAPL?
IMRX (Immuneering Corp) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMRX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMRX or AAPL?
AAPL has higher revenue growth at 0.2% vs -1.0% for IMRX.
Which company is more profitable: IMRX or AAPL?
Immuneering Corp (IMRX) has higher gross margins at 34907.7% compared to 47.3% for AAPL.
Which is the larger company: IMRX or AAPL?
Immuneering Corp (IMRX) is larger with a market cap of $356.88M compared to N/A for AAPL.
Should I buy IMRX or AAPL in 2026?
Both IMRX and AAPL have investment merit. IMRX trades at $5.70 while AAPL trades at $259.25. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMRX and AAPL stock?
Key differences: Market Cap ($356.88M vs N/A), P/E Ratio (N/A vs 33.0x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (34907.7% vs 47.3%).